| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |